SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

The Board of SMS Pharmaceuticals at its meeting held on 05 August 2024 has approved to incorporate a Subsidiary Company in India as a Company for Contract Research Organization (CRO) services on Peptides. Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals rose 76.45% to Rs 16.48 crore in the quarter ended June 2024 as against Rs 9.34 crore during the previous quarter ended June 2023. Sales rose 21.51% to Rs 164.45 crore in the quarter ended June 2024 as against Rs 135.34 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales164.45135.34 22 OPM %20.3819.35 - PBDT30.2120.37 48 PBT21.8312.68 72 NP16.489.34 76 Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live News

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News